Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
FRANCE –CardioRenal, a Grenoble-based company that specializes in improving the treatment of patients with severe chronic renal disease (CKD) at home, has raised US$3.7 million in seed funding. The backers…
Read More
KENYA – Kenyatta National Hospital (KNH) has called for people to undergo early screening for chronic kidney disease (CKD) to allow implementation of therapeutic interventions which reduces the high mortality…
Read More
LIBERIA – Liberian President George Manneh Weah has commissioned a new National Dialysis Center with a 10-bed capacity in Monrovia to boost kidney disease treatment especially for patients with acute…
Read More
USA – BenevolentAI, a leading clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery collaboration with AstraZeneca, doubling the number of disease areas under investigation. The three-year extension…
Read More
USA – An FDA advisory committee has delivered a crushing blow to Reata Pharma, voting unanimously that the drugmaker’s data on bardoxolone – a drug used to treat kidney disease…
Read More
ZIMBABWE – Kidney patients in Zimbabwe will benefit from a US$15 000 haemodialysis machine which has been donated to Gwanda Provincial Hospital by Stanbic Bank. The dialysis machine will assist…
Read More
UNITED KINGDOM – GlaxoSmithKline Plc (GSK) has reported positive trial results for Daprodustat, a potential blockbuster anemia pill that the drugmaker hopes will bolster its pharma portfolio as it prepares…
Read More
KENYA- Cost for covering renal dialysis has more than tripled over the last four years, as NHIF paid a whooping Ksh. 3.8 billion to cover dialysis expenses, indicating the growth…
Read More
USA – The Food and Drug Administration has approved Cara Therapeutics’s drug to treat moderate-to-severe itching in patients with chronic kidney disease undergoing dialysis, making it the first therapy for…
Read More
US – Bayer’s first-in-class nonsteroidal drug Kerendia is now available in the US for use following an approval as a therapy that can slow chronic kidney disease progression in patients…
Read More